RGRaul Angel Garcia

Raul Angel Garcia

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Raul Angel Garcia has a total of 37 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Association of Acute Kidney Injury Risk and Same‐Day Discharge Practices After Percutaneous Coronary Intervention

    by Anezi Uzendu, Rayan El Zein, Jennifer A. Rymer, Dan D. Nguyen, R. Angel Garcia, Nobuhiro Ikemura, Neel Butala, Howard M. Julien, Saket Girotra, Dharam J. Kumbhani, et al.

    Background: Same‐day discharge (SDD) after percutaneous coronary intervention (PCI) may be altered when complications occur. We sought to determine whether risk of the most common complication, acute kidney injury (AKI), is associated with SDD in practice. Methods: Using the NCDR (National Cardiovascular Data Registry) CathPCI registry, we calculated the AKI risk for elective PCIs from 2018 to 2022 using the NCDR prediction model. Hierarchical logistic regression models were constructed to predict SDD with AKI risk and procedural variables as fixed effects, and site as a random effect. Trends in SDD rate across AKI risk categories were described and variability across sites was quantified using median odds ratios (ORs). Results: Among 1 033 096 eligible patients, 414 297 (40.1%) had SDD after PCI and rates increased throughout the study period (27.9% in 2018 to 53.4% in 2022; 1.9% per quarter). Higher AKI risks were associated with lower SDD rates (OR, 0.97 per 1% increase in AKI risk [95% CI 0.968–0.971]) although even in 2022, 41.2% of high‐risk patients underwent SDD. Marked variation in SDD practices was observed across sites (overall median OR, 3.75 [95% CI 2.63–5.34]) even among the highest risk group (median OR, 3.60 [95% CI 2.34–5.56]). Conclusions: Although patients at higher risk of AKI are less likely to undergo SDD overall, currently, 2 in 5 patients with >10% AKI risk are discharged the day of their procedure with marked variation across sites. Further work is needed to better understand the postdischarge risk of SDD in patients at higher AKI risk to improve delivery and safety of PCI.


  • Association of Medication Adherence With Health Outcomes in the ISCHEMIA Trial

    by R. Angel Garcia, John A. Spertus, Mary C. Benton, Philip G. Jones, Daniel B. Mark, Jonathan D. Newman, Sripal Bangalore, William E. Boden, Gregg W. Stone, Harmony R. Reynolds, et al.


  • Variation in Out-of-Hospital Cardiac Arrest Survival Across Emergency Medical Service Agencies

    by Raul A. Garcia, Saket Girotra, Philip G. Jones, Bryan McNally, John A. Spertus, Paul S. Chan, on behalf of the CARES Surveillance Group

    Background: Although studies have reported variation in out-of-hospital cardiac arrest (OHCA) survival by geographic location, little is known about variation in OHCA survival at the level of emergency medical service (EMS) agencies—which may have modifiable practices, unlike counties and regions. We quantified the variation in OHCA survival across EMS agencies and explored whether variation in 2 specific EMS resuscitation practices were associated with survival to hospital admission. Methods: Within the Cardiac Arrest Registry to Enhance Survival, a prospective registry representing ≈51% of the US population, we identified 258 342 OHCAs from 764 EMS agencies with > 10 OHCA cases annually during 2015 to 2019. Using hierarchical logistic regression, risk-standardized rates of survival to hospital admission were computed for each EMS agency. We quantified inter-agency variation in survival with median odds ratios and assessed the association of 2 resuscitation practices (EMS response time and the proportion of OHCAs with termination of resuscitation without meeting futility criteria) with EMS agency survival rates to hospital admission. Results: Across 764 EMS agencies comprising 258 342 OHCAs, the median risk-standardized rate of survival to hospital admission was 27.3% (interquartile range, 24.5%–30.1%; range: 16.0%–45.6%). The adjusted median odds ratio was 1.35 (95% CI, 1.32–1.39), denoting that the odds of survival of 2 patients with identical covariates varied by 35% at 2 randomly selected EMS agencies. EMS agencies in the lowest quartile of risk-standardized survival had longer EMS response times when compared with the highest quartile (12.0±3.4 versus 9.0±2.6 minutes; P P <0.001). Conclusions: Survival after OHCA varies widely across EMS agencies. EMS response times and termination of resuscitation practices were associated with agency-level rates of survival to hospital admission, suggesting potentially modifiable practices which can improve OHCA survival.


  • Open Access

    LVAD Vasculitis Case Series

    by Raul Angel Garcia, Safwan Gaznabi, Lewis Musoke, Michael Osnard, Kathir Balakumaran, Keith B. Armitage, Sadeer G. Al-Kindi, Mahazarin Ginwalla, Yasir Abu-Omar, Chantal A. Elamm


  • Patient-Reported Outcomes in Patients with Cardiomyopathy

    by Raul Angel Garcia, Mary C. Benton, John A. Spertus

    Purpose of Review As medicine strives to become more patient-centered, patient-reported outcomes (PROs) are often used to describe patients’ symptoms, function, and quality of life. This review describes the key concepts of PROs specific to heart failure in clinical trials and their potential role in clinical practice. Recent Findings As the Food and Drug Administration has increasingly emphasized how it values PROs as clinical outcome assessments, including its recent qualification of the Kansas City Cardiomyopathy Questionnaire (KCCQ), clinical trials have increasingly used them to evaluate novel therapies. This has been enhanced by an increasing understanding of how to interpret KCCQ scores. Its use in clinical practice, including the importance of providers sharing results with their patients, is just emerging. Summary PROs provide unique insights into the benefits of treatment from patients’ perspectives and while their role in clinical care is just beginning, they offer an important opportunity to improve the patient-centeredness of care.